Literature DB >> 10875595

Surgical treatment for chronic thromboembolic pulmonary hypertension under profound hypothermia and circulatory arrest in 24 patients.

M Ando1, Y Okita, O Tagusari, S Kitamura, N Nakanishi, S Kyotani.   

Abstract

BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious disease that induces hypoxemia and pulmonary hypertension, eventually leading to respiratory failure and right heart failure. We evaluated the results of surgical treatment in patients undergoing circulatory arrest under profound hypothermia.
METHODS: Between February 1995 and June 1999, 24 cases of CTEPH were surgically treated. The age of patients (11 males and 13 females) ranged from 21 to 71 years (mean 49+/-15 years). Because of hypoxemia, severe pulmonary hypertension (mean pulmonary artery pressure 45+/-7 mmHg ), and low cardiac output, the functional class of these patients was New York Heart Association (NYHA) III or IV. Following a median sternotomy, profound hypothermia was induced using cardiopulmonary bypass, and pulmonary thromboendarterectomy in the bilateral pulmonary arteries was performed under intermittent circulatory arrest. Surgery was performed emergently in four patients.
RESULTS: Of these 24 patients, 2 of 20 patients who underwent elective surgery and 3 of 4 patients who underwent emergent surgery died in the hospital. Symptoms of CTEPH markedly improved in 18 patients who survived the surgery. Pulmonary arterial pressure was decreased to 16+/-6 mmHg, and cardiac output was increased.
CONCLUSIONS: When CTEPH is resistant to medical treatment, surgical treatment is useful. When surgical indications are carefully selected, pulmonary thromboendarterectomy using intermittent circulatory arrest under profound hypothermia is quite effective for treating CTEPH.

Entities:  

Mesh:

Year:  1999        PMID: 10875595     DOI: 10.1111/j.1540-8191.1999.tb01014.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  6 in total

1.  Pulmonary thromboendarterectomy for chronic pulmonary thromboembolism in protein C deficiency.

Authors:  Masato Yoshida; Nobuhiko Mukohara; Hidefumi Obo; Nobuchika Ozaki; Tsutomu Shida; Yutaka Okita
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-02

Review 2.  Recent advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension including Japanese experiences.

Authors:  Hitoshi Ogino
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-09-26

Review 3.  Balloon pulmonary angioplasty vs. pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.

Authors:  Liyan Zhang; Yuping Bai; Peijing Yan; Tingting He; Bin Liu; Shanlian Wu; Zhen Qian; Changtian Li; Yunshan Cao; Min Zhang
Journal:  Heart Fail Rev       Date:  2021-02-05       Impact factor: 4.214

4.  Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report.

Authors:  Konstantinos Porpodis; Maria Konoglou; Paul Zarogoulidis; Evangelos Kaimakamis; Theodoros Kontakiotis; Despoina Papakosta; Vasilis Zervas; Nikolaos Katsikogiannis; Nikolaos Courcoutsakis; Alexandros Mitrakas; Panagiotis Touzopoulos; Michael Karanikas; Konstantinos Zarogoulidis; Aikaterini Markopoulou
Journal:  Int J Gen Med       Date:  2011-11-08

5.  Recurrent symptomatic ischemic stroke in a 46-year-old African male revealing Angio-Behçet with severe cardiovascular involvement.

Authors:  Ba Djibril Marie; Diack Aminata; Mboup Mouhamed Cherif; Fall Moussa Daouda
Journal:  Egypt Heart J       Date:  2016-10-13

6.  Sequential Hybrid Therapy With Pulmonary Endarterectomy and Additional Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Kenichi Yanaka; Kazuhiko Nakayama; Toshiro Shinke; Yuto Shinkura; Yu Taniguchi; Hiroto Kinutani; Naoki Tamada; Hiroyuki Onishi; Yasunori Tsuboi; Seimi Satomi-Kobayashi; Hiromasa Otake; Hiroshi Tanaka; Yutaka Okita; Noriaki Emoto; Ken-Ichi Hirata
Journal:  J Am Heart Assoc       Date:  2018-06-21       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.